Samyang Biopharm Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Stock Symbol
  • 0120G0

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $30.06
  • (As of Monday Closing)

Samyang Biopharm General Information

Description

Samyang Biopharm Corp develops, manufactures, and supplies medical devices, pharmaceutical products, and gene - therapeutics, aiming to deliver healthcare solutions.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 295, Pangyo-ro, Bundang-gu
  • Seongnam, Gyeonggi 13488
  • South Korea
+82
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Pharmaceuticals
Other Devices and Supplies
Stock Exchange
KRX
Corporate Office
  • 295, Pangyo-ro, Bundang-gu
  • Seongnam, Gyeonggi 13488
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Samyang Biopharm Stock Performance

As of 16-Nov-2026, Samyang Biopharm’s stock price is $30.06. Its current market cap is $224M with 7.44M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$30.06 $30.24 $15.80 - $100.39 $224M 7.44M 56.1K

Samyang Biopharm Financials Summary

As of 31-Dec-2024, Samyang Biopharm has a trailing 12-month revenue of $101M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024
Revenue 101,287 101,287
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Samyang Biopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Samyang Biopharm‘s full profile, request access.

Request a free trial

Samyang Biopharm Patents

Samyang Biopharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026192441-A1 Nanoparticle composition for lung-selective drug delivery Pending 13-Mar-2025
WO-2026186988-A1 Cationic lipid, method for preparing same, and composition of nanoparticles for drug delivery comprising same Pending 04-Mar-2025
WO-2026142373-A1 Novel compound having targeting site introduced through biodegradable linker and method for preparing same Pending 27-Dec-2024
WO-2026142012-A1 Lipid, preparation method therefor, and composition of nanoparticles for drug delivery comprising same Pending 26-Dec-2024
WO-2026127599-A1 Novel lipid and method for preparing same Pending 10-Dec-2024 C07C335/02
To view Samyang Biopharm’s complete patent history, request access »

Samyang Biopharm Investments & Acquisitions (2)

Samyang Biopharm’s most recent deal was a Merger/Acquisition with Medichem (Medical Supplies). The deal was made on 01-Jan-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Medichem (Medical Supplies) 01-Jan-2017 Merger/Acquisition Medical Supplies
JB Financial Group 17-Jan-2014 PIPE Holding Companies
To view Samyang Biopharm’s complete investments and acquisitions history, request access »

Samyang Biopharm ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Distribution

Subindustry

Rank

Percentile

To view Samyang Biopharm’s complete esg history, request access »

Samyang Biopharm FAQs

  • When was Samyang Biopharm founded?

    Samyang Biopharm was founded in 1995.

  • Where is Samyang Biopharm headquartered?

    Samyang Biopharm is headquartered in Seongnam, South Korea.

  • What industry is Samyang Biopharm in?

    Samyang Biopharm’s primary industry is Surgical Devices.

  • Is Samyang Biopharm a private or public company?

    Samyang Biopharm is a Public company.

  • What is Samyang Biopharm’s stock symbol?

    The ticker symbol for Samyang Biopharm is 0120G0.

  • What is the current stock price of Samyang Biopharm?

    As of 16-Nov-2026 the stock price of Samyang Biopharm is $30.06.

  • What is the current market cap of Samyang Biopharm?

    The current market capitalization of Samyang Biopharm is $224M.

  • What is Samyang Biopharm’s current revenue?

    The trailing twelve month revenue for Samyang Biopharm is $101M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process